Our data demonstrated that Rab25 expression to levels found in human tumors with RAB25 amplification, which is associated with aggressiveness of breast and ovarian cancer [23], increases OPG levels in the supernatant of cancer cells. This evidence concerns the gene RAB25 and ovarian cancer.